Chiesi, Cornerstone Therapeutics sales and marketing update

Chiesi granted Cornerstone U.S. rights to market Bethkis tobramycin inhalation solution. The inhaled tobramycin solution was approved last month to manage Pseudomonas aeruginosa infections in patient...